Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
1,995
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Successful treatment of alopecia universalis with abrocitinib: a case report

Jie- ZhangDepartment of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic diseases, Beijing, ChinaView further author information
&
Ya-Gang ZuoDepartment of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic diseases, Beijing, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2526-4331View further author information
ORCID Icon
Article: 2242706 | Received 10 Apr 2023, Accepted 20 Jun 2023, Published online: 01 Aug 2023

References

  • Deeks ED, Duggan S. Abrocitinib: first approval. Drugs. 2021;81(18):1–3. doi:10.1007/s40265-021-01638-3.
  • Zhao J, Liu L. A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib. JAAD Case Rep. 2022;22:99–100. doi:10.1016/j.jdcr.2022.02.027.
  • Bennett M, Moussa A, Sinclair R. Successful treatment of chronic severe alopecia areata with abrocitinib. Australas J Dermatol. 2022;63(2):274–276. doi:10.1111/ajd.13836.
  • Lee JW, Yu DA, Cho S, et al. Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): a multicentric retrospective case series. J Dermatol. 2023;50:814–819.
  • Krivda LK, Campagna LJ, Mignano MS, et al. Prolonged drug-induced hypersensitivity syndrome/DRESS with alopecia areata and autoimmune thyroiditis. Fed Pract. 2022;39(8):350–354.
  • Aksoy H, Karadag AS, Turgut Erdemir VA, et al. Alopecia universalis following DRESS, where rarities merge. Dermatol Ther. 2021;34(2):e14842.
  • Zhou C, Li X, Wang C, et al. Alopecia areata: an update on etiopathogenesis, diagnosis, and management. Clin Rev Allergy Immunol. 2021;61(3):403–423. doi:10.1007/s12016-021-08883-0.
  • Liu LY, Craiglow BG, Dai F, et al. Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients. J Am Acad Dermatol. 2017;76(1):22–28. doi:10.1016/j.jaad.2016.09.007.
  • Hollingsworth P, Paci K, Evans M, et al. Alopecia universalis after drug reaction with eosinophilia and systemic symptoms (dress). Pediatr Dermatol. 2020;37(5):947–949. doi:10.1111/pde.14217.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.